At this moment, on the White House’s official website for petitioning the government, the only thing as popular as legalizing marijuana and separating church from state is a petition to “Direct the Patent Office to Cease Issuing Software Patents.”
There are lots of good reasons to end the practice of patenting software, including the fact that software patents are primarily a vehicle for transferring wealth from the innovators who create it to patent trolls whose sole “product” is litigation. (Software patents are also sometimes used by big companies to take their rivals down a peg or two, in what seems like an effort to pile up so many cross-licensing fees that they all cancel each other out.)
Anyway, if you agree that this madness must stop, you’d better get yourself over to WhiteHouse.gov, because as of the last time I reloaded that site, the petition still needed 531 more signatures in order to merit an official response.
Unfortunately, that “official response”—a written statement—is about all anyone can expect from this effort. It seems that even though the U.S. Constitution provides an avenue for citizens to petition their government, it says nothing about how the government should handle those petitions.
Hopefully someone’s at least posting them over the water cooler, so administration decision-makers can get a sense of how those other branches of the government are failing to address one of the technology industry’s most pressing issues.
Meta has built a massive new language AI—and it’s giving it away for free
Facebook’s parent company is inviting researchers to pore over and pick apart the flaws in its version of GPT-3
The gene-edited pig heart given to a dying patient was infected with a pig virus
The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.
Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging
The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.
Yann LeCun has a bold new vision for the future of AI
One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.